Stifel Financial’s bluebird bio BLUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-519
Closed -$31.5K 3332
2023
Q3
$31.5K Buy
+519
New +$36.5K ﹤0.01% 3217
2021
Q1
Sell
-733
Closed -$411K 3213
2020
Q4
$411K Sell
733
-359
-33% -$228K ﹤0.01% 2437
2020
Q3
$763K Buy
1,092
+203
+23% +$158K ﹤0.01% 1817
2020
Q2
$703K Buy
889
+221
+33% +$167K ﹤0.01% 1789
2020
Q1
$394K Buy
668
+117
+21% +$114K ﹤0.01% 2010
2019
Q4
$624K Buy
551
+24
+5% +$26.1K ﹤0.01% 2125
2019
Q3
$621K Sell
527
-29
-5% -$44.3K ﹤0.01% 2038
2019
Q2
$922K Sell
556
-145
-21% -$251K ﹤0.01% 1856
2019
Q1
$1.43M Buy
701
+228
+48% +$401K ﹤0.01% 1438
2018
Q4
$600K Buy
473
+285
+152% +$437K ﹤0.01% 1844
2018
Q3
$357K Buy
+188
New +$388K ﹤0.01% 2255
2017
Q4
Sell
-220
Closed -$391K 2658
2017
Q3
$391K Buy
+220
New +$307K ﹤0.01% 2029

Other funds holding BLUE

Stifel Financial's BLUE Position: Q4 2023 in Review

Stifel Financial sold out of bluebird bio (BLUE) in Q4 2023, closing a stake of 519 shares — an estimated $31.5K sold.

Stifel Financial first reported a position in BLUE in Q3 2017 and held it in 12 quarters. The position peaked at $1.43M in Q1 2019. 187 funds tracked by Wall St. Rank hold BLUE as of Q4 2023.

  • Stifel Financial reported no remaining bluebird bio position as of Q4 2023 after selling out during the quarter.
  • Stifel Financial sold 519 bluebird bio shares in Q4 2023, an estimated $31.5K.
  • Stifel Financial first reported a position in bluebird bio in Q3 2017 and held it in 12 quarters.
  • Stifel Financial's bluebird bio position peaked at $1.43M in Q1 2019.
  • 187 funds tracked by Wall St. Rank held bluebird bio as of Q4 2023.

Based on Stifel Financial's 13F filing for Q4 2023, filed 12 Feb 2024.